Letters sent to healthcare professionals in April 2016

In April 2016, letters were sent regarding canagliflozin (Invokana▼, Vokanamet▼), BCR-ABL tyrosine kinase inhibitors, pomalidomide (Imnovid▼), and retigabine (Trobalt)

In April 2016, letters were sent to healthcare professionals regarding:

Article citation: Drug Safety Update Vol 9 issue 10 May 2016 4.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.